<DOC>
	<DOC>NCT00623467</DOC>
	<brief_summary>This is a study involving the use of Magnetic Resonance Imaging (MRI) contrast agents called Gadavist. The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Gadavist when used for taking images of the brain and spine. The results of the MRI will be compared to the results of images taken without Gadavist.</brief_summary>
	<brief_title>Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging</brief_title>
	<detailed_description>Issues on safety will be addressed in Adverse Events section.</detailed_description>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Central Nervous System Diseases</mesh_term>
	<criteria>Patients referred for contrast enhanced MRI of the CNS based on symptoms or previous procedures. Patients with acute renal insufficiency Patients with severe renal disease Patients with any contraindication to magnetic resonance imaging.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Central Nervous System Imaging</keyword>
	<keyword>Diagnostic Imaging</keyword>
</DOC>